Danhong Injection in the Treatment of Chronic Stable Angina

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 920 participants.

Also called NCT01681316

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 920 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01681316
Other papers using this trial's data
  • Detection of an anti-angina therapeutic module in the effective population treated by a multi-target drug Danhong injection: a randomized trial Signal transduction and targeted therapy, 2021-09-01 DOI, PubMed 34471087, PMC8410855 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
China (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01681316. Randomized; quadruple masking; primary purpose treatment. Start 2012-12 (registry gives no type); primary completion 2016-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Danhong Injection in the Treatment of Chronic Stable Angina
Condition
Chronic Stable Angina
Intervention (Drug)
Danhong injection
Intervention (Other)
Standard medical care
Intervention (Drug)
Placebo
Lead sponsor
China Academy of Chinese Medical Sciences (class: other)
Collaborator
China Food and Drug Administration (class: other government)

Record details

Record id
cardio:ct-nct01681316
Content hash
239dbe3a6cefb0a352bca9e3a65a480dd85600713281ef45d9bc5681c2ac5e7d